Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Puma Biotechnology (PBYI) PT Lowered to $7 at Cowen
-
Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
-
Puma Biotechnology (PBYI) PT Raised to $21 at Cowen
-
Puma Biotechnology (PBYI) PT Lowered to $25 at Cowen
-
Puma Biotechnology (PBYI) PT Raised to $28 at Cowen
-
Puma Biotechnology (PBYI) PT Lowered to $27 at Cowen
-
Puma Biotechnology (PBYI) PT Lowered to $41 at Cowen
-
Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
-
Puma Biotechnology to Present at Cowen’s Annual Healthcare Conference
-
Cowen Downgrades Puma Biotechnology (PBYI) to Market Perform, 'EU Approval Appears Unlikely'
-
Puma Biotech (PBYI): Solid Start for NERLYNX - Cowen
-
Puma Biotechnology (PBYI) PT Raised to $120 at Cowen; Source Suggest Nerlynx Price of $10,500/month
-
Cowen Upgrades Puma Biotechnology (PBYI) to Outperform; Expects FDA Approval with Broad Label
-
Puma Biotechnology (PBYI) AdCom Dcos 'Appear Neutral' Cowen
-
Puma Biotechnology to Present at Cowen’s Health Care Conference
-
Cowen Assumes Puma Biotechnology (PBYI) at Market Perform
-
Puma Biotechnology to Present at Cowen’s Health Care Conference
-
Streetinsider.com's Hot Lunchtime Reads 6/1: (BAC) (DISH) (AMZN) (MSFT) (JNPR)
-
Notable Analyst Rating Changes 5/5: (NFLX) (ALU) (ARRS) Upgraded; (BIDU) (AOL) (GNW) Downgraded
-
UPDATE: Cowen Downgrades Puma Biotechnology (PBYI) to Market Perform
-
Puma Biotech (PBYI) Closes $205M Share Offering
-
Puma Biotech (PBYI) to Offer 1M Shares
-
Puma Biotech (PBYI) Prices 979.6K Offering at $122.50/Share
-
Cowen Starts Puma Biotechnology (PBYI) at Outperform

